ARTICLE | Company News
Bionetworks GmbH, onepharm deal
June 2, 2008 7:00 AM UTC
onepharm acquired IP from Bionetworks covering technology that stops bone loss in periodontitis. The acquisition includes OPM-3023, a small molecule that is expected to start a Phase I trial by year ...